Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.

Sequeira G; Vanzulli SI; Rojas P; Lamb C; Colombo L; May MXEA; Molinolo A; Lanari C

doi:10.18632/oncotarget.28842

← 뒤로

Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.

Oncotarget 2026 Vol.17(1) p. 137-138

Sequeira G, Vanzulli SI, Rojas P, Lamb C, Colombo L, May MXEA, Molinolo A, Lanari C

PMC 전문 ↗ 원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Sequeira G, Vanzulli SI, et al. (2026). Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.. Oncotarget, 17(1), 137-138. https://doi.org/10.18632/oncotarget.28842

MLA Sequeira G, et al.. "Correction: The effectiveness of nano chemotherapeutic particles combined with mifepristone depends on the PR isoform ratio in preclinical models of breast cancer.." Oncotarget, vol. 17, no. 1, 2026, pp. 137-138.

PMID 41954990

DOI 10.18632/oncotarget.28842